[Smoking withdrawal treatment with Cytisin (Tabex). Results of a semi-annual survey of former smokers after 4 weeks of therapy]
[Article in German]
- PMID:5524300
Item in Clipboard
[Smoking withdrawal treatment with Cytisin (Tabex). Results of a semi-annual survey of former smokers after 4 weeks of therapy]
[Article in German]
S Benndorf et al. Dtsch Gesundheitsw..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.Shiffman S.Shiffman S.Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019.Clin Ther. 2008.PMID:18803988Clinical Trial.
- Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA.Hurt RD, et al.Arch Pediatr Adolesc Med. 2000 Jan;154(1):31-7.Arch Pediatr Adolesc Med. 2000.PMID:10632247Clinical Trial.
- Nicotine patch therapy in adolescent smokers.Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.Smith TA, et al.Pediatrics. 1996 Oct;98(4 Pt 1):659-67.Pediatrics. 1996.PMID:8885942Clinical Trial.
- Cytisine for smoking cessation: a literature review and a meta-analysis.Etter JF.Etter JF.Arch Intern Med. 2006 Aug 14-28;166(15):1553-9. doi: 10.1001/archinte.166.15.1553.Arch Intern Med. 2006.PMID:16908787Review.
- [Depression and smoking].Aubin HJ, Tilikete S, Barrucand D.Aubin HJ, et al.Encephale. 1996 Jan-Feb;22(1):17-22.Encephale. 1996.PMID:8681871Review.French.
Cited by
- New medications development for smoking cessation.Lengel D, Kenny PJ.Lengel D, et al.Addict Neurosci. 2023 Sep;7:100103. doi: 10.1016/j.addicn.2023.100103. Epub 2023 May 18.Addict Neurosci. 2023.PMID:37519910Free PMC article.
- Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.Xi ZX.Xi ZX.Drug Healthc Patient Saf. 2010 Apr 1;2010(2):39-48. doi: 10.2147/DHPS.S6299.Drug Healthc Patient Saf. 2010.PMID:21278851Free PMC article.
- Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.Harmey D, Griffin PR, Kenny PJ.Harmey D, et al.Nicotine Tob Res. 2012 Nov;14(11):1300-18. doi: 10.1093/ntr/nts201. Epub 2012 Sep 27.Nicotine Tob Res. 2012.PMID:23024249Free PMC article.Review.
- Nicotine receptor partial agonists for smoking cessation.Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N.Livingstone-Banks J, et al.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.Cochrane Database Syst Rev. 2023.PMID:37142273Free PMC article.Review.
- Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study.Torazzi A, Tedesco E, Ceccato S, Santin L, Campagnari S, Losso L, Toldo S, Casari R, Arzenton E, Marini P, Chiamulera C, Lugoboni F.Torazzi A, et al.Front Public Health. 2024 Sep 30;12:1350176. doi: 10.3389/fpubh.2024.1350176. eCollection 2024.Front Public Health. 2024.PMID:39403432Free PMC article.